ENTRY       D08936                      Drug
NAME        Labetuzumab (INN/USAN)
EFFICACY    Antineoplastic, Anti-CEA antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of colorectal cancer
TARGET      CEACAM [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               CAMs
                CEACAM
                 D08936  Labetuzumab (INN/USAN)
DBLINKS     CAS: 219649-07-7
            PubChem: 96025619
///
